SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-042354
Filing Date
2020-09-02
Accepted
2020-09-02 16:01:20
Documents
73
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alvr-10q_20200630.htm 10-Q 2454851
2 EX-31.1 alvr-ex311_6.htm EX-31.1 19020
3 EX-31.2 alvr-ex312_7.htm EX-31.2 19061
4 EX-32.1 alvr-ex321_8.htm EX-32.1 9662
5 EX-32.2 alvr-ex322_9.htm EX-32.2 9704
  Complete submission text file 0001564590-20-042354.txt   7267867

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alvr-20200630.xml EX-101.INS 1360865
7 XBRL TAXONOMY EXTENSION SCHEMA alvr-20200630.xsd EX-101.SCH 54822
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alvr-20200630_cal.xml EX-101.CAL 37226
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alvr-20200630_def.xml EX-101.DEF 185271
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alvr-20200630_lab.xml EX-101.LAB 393687
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alvr-20200630_pre.xml EX-101.PRE 324553
Mailing Address 139 MAIN STREET, SUITE 500 CAMBRIDGE MA 02142
Business Address 139 MAIN STREET, SUITE 500 CAMBRIDGE MA 02142 (617) 433-2605
Allovir, Inc. (Filer) CIK: 0001754068 (see all company filings)

IRS No.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39409 | Film No.: 201156937
SIC: 2836 Biological Products, (No Diagnostic Substances)